AEterna Zentaris completes sale of Quebec City building for $7.1M

AEterna Zentaris Inc. (Nasdaq:AEZS) said Friday the Canada-based company had completed the sale of its Quebec City property for $7.1 million in cash. The proceeds will fund the biopharmaceutical company’s Phase 3 program with cetrorelix in benign prostatic hyperplasia, the company said Friday. Shares of AEterna Zentaris were up about 6% in pre-market trading, with shares at $1.06 ahead of the bell.
For detailed price information and recent news stories about AEterna Zentaris Inc., click AEZS.
For detailed price information and recent news stories about AEterna Zentaris Inc., click AEZS.









(click a star)
Enter comment: